NASDAQ : RADX
Radiopharm Theranostics Limited — Financial statements
Healthcare · Biotechnology · Australia
Last price 1.1164 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Radiopharm Theranostics Limited (RADX) reported revenue of 12.87M AUD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 2.77M | 2.77M | 3.63M | 299.23K | 292.36K | |
| Other Revenue | 10.10M | 10.10M | 9.37M | 1.29M | 5.92M | |
| Revenue | 12.87M | 12.87M | 13.00M | 1.59M | 6.21M | |
| Cost of Revenue | 47.20M | 47.20M | 31.11M | 21.61M | 19.53M | 7.49M |
| Gross Profit | -34.34M | -34.34M | -18.11M | -20.02M | -13.32M | -7.49M |
| Selling, General & Admin | 16.22M | 16.22M | 14.64M | 13.04M | 12.23M | 7.64M |
| Operating Expenses | 18.62M | 18.62M | 16.53M | 15.68M | 15.27M | 12.44M |
| Operating Income | -52.96M | -52.96M | -34.64M | -35.69M | -28.59M | -19.93M |
| Interest Expense | -112.40K | -112.40K | -65.30K | -642.89K | -86.09K | -9.35M |
| Interest & Investment Income | 637.14K | 637.14K | 888.20K | 50.48K | 145.03K | 8.83K |
| Currency Exchange Gain (Loss) | -655.39K | -655.39K | 138.14K | 94.96K | -257.25K | -1.11M |
| EBT Excluding Unusual Items | -53.09M | -53.09M | -33.68M | -36.19M | -28.79M | -30.38M |
| Gain (Loss) on Sale of Assets | -212.77K | -212.77K | -1.69M | |||
| Asset Writedown | -5.27M | -5.27M | -1.48M | -3.10M | ||
| Other Unusual Items | 1.67M | 1.67M | -4.56M | -8.49M | -2.68M | |
| Pretax Income | -56.90M | -56.90M | -38.24M | -47.85M | -34.57M | -30.38M |
| Income Tax Expense | 54.44K | 54.44K | 103.29K | 96.36K | 38.01K | 44.40K |
| Net Income | -56.95M | -56.95M | -38.34M | -47.95M | -34.61M | -30.42M |
| Net Income to Common | -56.95M | -56.95M | -38.34M | -47.95M | -34.61M | -30.42M |
| Shares Outstanding (Basic) | 3.07B | 3.07B | 2.08B | 386.46M | 305.83M | 181.25M |
| Shares Outstanding (Diluted) | 3.07B | 3.07B | 2.08B | 386.46M | 305.83M | 181.25M |
| EPS (Basic) | -0.02 | -0.02 | -0.02 | -0.12 | -0.11 | -0.17 |
| EPS (Diluted) | -0.02 | -0.02 | -0.02 | -0.12 | -0.11 | -0.17 |
| Free Cash Flow | -52.78M | -52.78M | -36.65M | -22.98M | -23.25M | -9.91M |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.06 | -0.08 | -0.06 |
| Gross Margin | -266.89% | -266.89% | -139.27% | -214.52% | ||
| Operating Margin | -411.63% | -411.63% | -266.43% | -2,242.42% | -460.41% | |
| Profit Margin | -442.67% | -442.67% | -294.90% | -3,012.25% | -557.36% | |
| Free Cash Flow Margin | -410.28% | -410.28% | -281.85% | -1,443.39% | -374.36% | |
| EBITDA | -50.25M | -50.25M | -32.05M | -32.57M | -25.29M | -16.94M |
| EBITDA Margin | -246.46% | |||||
| D&A For EBITDA | 2.71M | 2.71M | 2.60M | 3.13M | 3.30M | 2.98M |
| EBIT | -52.96M | -52.96M | -34.64M | -35.69M | -28.59M | -19.93M |
| EBIT Margin | -266.43% |
Balance sheet
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.14M | 4.14M | 29.12M | 18.58M | 11.70M | 26.98M |
| Cash & Short-Term Investments | 4.14M | 4.14M | 29.12M | 18.58M | 11.70M | 26.98M |
| Accounts Receivable | 1.23M | 1.23M | 104.71K | 56.41K | ||
| Other Receivables | 16.22M | 16.22M | 10.40M | 987.41K | 4.36M | 73.00 |
| Receivables | 17.45M | 17.45M | 10.40M | 987.41K | 4.47M | 56.48K |
| Other Current Assets | 340.19K | 340.19K | 337.09K | 3.29M | 133.13K | 228.82K |
| Total Current Assets | 21.93M | 21.93M | 39.85M | 22.85M | 16.30M | 27.26M |
| Property, Plant & Equipment | 46.14K | 46.14K | 53.47K | 60.80K | 68.33K | 1.58K |
| Other Intangible Assets | 38.16M | 38.16M | 46.57M | 49.09M | 58.54M | 56.08M |
| Other Long-Term Assets | 40.00K | 40.00K | 40.00K | |||
| Total Assets | 60.13M | 60.13M | 86.48M | 72.04M | 74.95M | 83.38M |
| Accounts Payable | 5.47M | 5.47M | 6.35M | 6.43M | 2.96M | 1.19M |
| Accrued Expenses | 5.53M | 5.53M | 3.20M | 2.57M | 2.11M | 1.02M |
| Current Unearned Revenue | 806.41K | 806.41K | 1.72M | |||
| Other Current Liabilities | 7.09M | 7.09M | 3.66M | 8.57M | 8.16M | 5.66M |
| Total Current Liabilities | 18.90M | 18.90M | 14.93M | 17.58M | 13.23M | 7.88M |
| Other Long-Term Liabilities | 18.91M | 18.91M | 28.68M | 27.11M | 16.14M | 12.54M |
| Total Liabilities | 37.81M | 37.81M | 43.61M | 44.68M | 29.37M | 20.42M |
| Common Stock | 209.93M | 209.93M | 176.56M | 100.68M | 97.23M | 86.76M |
| Retained Earnings | -199.66M | -199.66M | -145.73M | -111.34M | -65.35M | -30.91M |
| Comprehensive Income & Other | 14.41M | 14.41M | 13.97M | 38.78M | 12.51M | 7.11M |
| Total Common Equity | 24.69M | 24.69M | 44.79M | 28.12M | 44.38M | 62.96M |
| Minority Interest | -2.36M | -2.36M | -1.92M | -769.28K | 1.19M | |
| Shareholders' Equity | 22.32M | 22.32M | 42.87M | 27.35M | 45.58M | 62.96M |
| Total Liabilities & Equity | 60.13M | 60.13M | 86.48M | 72.04M | 74.95M | 83.38M |
| Net Cash (Debt) | 4.14M | 4.14M | 29.12M | 18.58M | 11.70M | 26.98M |
| Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.05 | 0.04 | 0.15 |
| Filing Date Shares Outstanding | 4.34B | 4.34B | 2.36B | 2.17B | 339.31M | 255.43M |
| Total Common Shares Outstanding | 3.54B | 3.54B | 2.36B | 460.37M | 339.31M | 255.43M |
| Working Capital | 3.03M | 3.03M | 24.92M | 5.27M | 3.07M | 19.39M |
| Book Value Per Share | 0.01 | 0.01 | 0.02 | 0.06 | 0.13 | 0.25 |
| Tangible Book Value | -13.47M | -13.47M | -1.78M | -20.96M | -14.16M | 6.89M |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.05 | -0.04 | 0.03 |
Cash flow statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -56.95M | -56.95M | -38.34M | -47.95M | -34.61M | -30.42M |
| Depreciation & Amortization | 2.71M | 2.71M | 2.60M | 3.13M | 3.30M | 2.98M |
| Loss (Gain) From Sale of Assets | 212.77K | 212.77K | 1.69M | |||
| Asset Writedown & Restructuring Costs | 5.27M | 5.27M | 1.48M | |||
| Stock-Based Compensation | 2.41M | 2.41M | 1.90M | 2.64M | 3.04M | 4.80M |
| Other Operating Activities | -1.27M | -1.27M | 3.16M | 8.99M | 1.13M | 10.48M |
| Change in Accounts Receivable | -7.05M | -7.05M | -9.41M | 3.48M | 1.51M | -50.13K |
| Change in Accounts Payable | 1.90M | 1.90M | 514.64K | 3.50M | 2.35M | 2.53M |
| Change in Other Net Operating Assets | -3.10K | -3.10K | 2.95M | 73.87K | 95.69K | -228.82K |
| Operating Cash Flow | -52.78M | -52.78M | -36.65M | -22.98M | -23.20M | -9.91M |
| Capital Expenditures | -45.31K | -2.75K | ||||
| Sale (Purchase) of Intangibles | 3.00M | -1.49M | -28.34M | |||
| Investment in Securities | -40.00K | |||||
| Other Investing Activities | -5.42M | -5.42M | -1.23M | -320.00K | ||
| Investing Cash Flow | -5.42M | -5.42M | 1.77M | -320.00K | -1.53M | -28.38M |
| Short-Term Debt Issued | 10.00K | |||||
| Long-Term Debt Issued | 7.37M | |||||
| Total Debt Issued | 7.37M | 10.00K | ||||
| Short-Term Debt Repaid | -69.00K | |||||
| Long-Term Debt Repaid | -1.90M | -5.17M | ||||
| Total Debt Repaid | -1.90M | -5.17M | -69.00K | |||
| Net Debt Issued (Repaid) | -1.90M | 2.20M | -59.00K | |||
| Issuance of Common Stock | 35.38M | 35.38M | 53.98M | 29.65M | 10.07M | 70.00M |
| Other Financing Activities | -2.00M | -2.00M | -6.65M | -1.65M | -854.76K | -4.83M |
| Financing Cash Flow | 33.37M | 33.37M | 45.43M | 30.20M | 9.22M | 65.11M |
| Foreign Exchange Rate Adjustments | -149.93K | -149.93K | -14.87K | -25.04K | 234.65K | 127.37K |
| Net Cash Flow | -24.98M | -24.98M | 10.54M | 6.88M | -15.28M | 26.95M |
| Free Cash Flow | -52.78M | -52.78M | -36.65M | -22.98M | -23.25M | -9.91M |
| Free Cash Flow Margin | -410.28% | -410.28% | -281.85% | -1,443.39% | -374.36% | |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.06 | -0.08 | -0.06 |
| Levered Free Cash Flow | -31.14M | -31.14M | -23.31M | -12.27M | -12.08M | -31.35M |
| Unlevered Free Cash Flow | -31.07M | -31.07M | -23.27M | -11.87M | -12.03M | -25.51M |
| Cash Income Tax Paid | -4.49M | -4.49M | -4.85M | -1.56M | ||
| Change in Working Capital | -5.15M | -5.15M | -5.95M | 7.05M | 3.95M | 2.25M |
Ratios
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 21.69M | 46.59M | 34.11M | 11.67M | 23.71M | 26.40M |
| Enterprise Value | 15.19M | 21.43M | 9.44M | 10.48M | 8.41M | 3.94M |
| Last Close Price | 1.08 | 4.19 | 4.64 | |||
| PS Ratio | 2.44 | 5.23 | 4.00 | 10.99 | 5.74 | |
| PB Ratio | 1.40 | 3.02 | 1.21 | 0.64 | 0.78 | 0.61 |
| P/TBV Ratio | 5.56 | |||||
| EV/Sales Ratio | 1.71 | 2.41 | 1.11 | 9.87 | 2.04 | |
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.68 | -0.68 | -0.26 | -0.43 |
| Net Debt / EBITDA Ratio | 0.08 | 0.08 | 0.91 | 0.57 | 0.46 | 1.59 |
| Net Debt / FCF Ratio | 0.08 | 0.08 | 0.80 | 0.81 | 0.50 | 2.72 |
| Asset Turnover | 0.17 | 0.17 | 0.16 | 0.02 | 0.08 | |
| Quick Ratio | 1.14 | 1.14 | 2.65 | 1.11 | 1.22 | 3.43 |
| Current Ratio | 1.16 | 1.16 | 2.67 | 1.30 | 1.23 | 3.46 |
| Return on Equity (ROE) | -174.71% | -174.71% | -109.20% | -131.49% | -63.78% | -96.82% |
| Return on Assets (ROA) | -45.15% | -45.15% | -27.32% | -30.36% | -22.57% | -29.86% |
| Return on Capital Employed (ROCE) | -128.40% | -128.40% | -48.40% | -65.50% | -46.30% | -26.40% |
| Earnings Yield | -361.38% | -84.57% | -73.69% | -274.09% | -97.15% | -79.40% |
| FCF Yield | -170.87% | -78.38% | -70.43% | -131.34% | -65.25% | -25.86% |
| Buyback Yield / Dilution | -47.68% | -47.68% | -438.49% | -26.36% | -68.74% |